NCT02299999 2025-01-15
SAFIR02_Breast
UNICANCER
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT00481845 2017-02-07
Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
Stanford University
Phase 2 Terminated
NCT00752986 2016-12-05
ZACFAST
Sanofi
Phase 2 Terminated
NCT00494481 2016-09-30
E3 Breast Cancer Taxotere Combination
Sanofi
Phase 2 Completed
NCT00034918 2016-08-24
This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer
Sanofi
Phase 2 Completed
NCT00811369 2013-11-18
ZAMBONEY
Ontario Clinical Oncology Group (OCOG)
Phase 2 Completed